1. Home
  2. HALO vs TPG Comparison

HALO vs TPG Comparison

Compare HALO & TPG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • HALO
  • TPG
  • Stock Information
  • Founded
  • HALO 1998
  • TPG 1992
  • Country
  • HALO United States
  • TPG United States
  • Employees
  • HALO N/A
  • TPG N/A
  • Industry
  • HALO Biotechnology: Biological Products (No Diagnostic Substances)
  • TPG Investment Managers
  • Sector
  • HALO Health Care
  • TPG Finance
  • Exchange
  • HALO Nasdaq
  • TPG Nasdaq
  • Market Cap
  • HALO 7.4B
  • TPG 6.6B
  • IPO Year
  • HALO N/A
  • TPG 2022
  • Fundamental
  • Price
  • HALO $55.01
  • TPG $47.32
  • Analyst Decision
  • HALO Buy
  • TPG Buy
  • Analyst Count
  • HALO 9
  • TPG 12
  • Target Price
  • HALO $63.56
  • TPG $62.36
  • AVG Volume (30 Days)
  • HALO 3.5M
  • TPG 2.4M
  • Earning Date
  • HALO 05-06-2025
  • TPG 05-07-2025
  • Dividend Yield
  • HALO N/A
  • TPG 3.62%
  • EPS Growth
  • HALO 55.40
  • TPG N/A
  • EPS
  • HALO 3.76
  • TPG N/A
  • Revenue
  • HALO $1,084,306,000.00
  • TPG $3,710,887,000.00
  • Revenue This Year
  • HALO $25.77
  • TPG N/A
  • Revenue Next Year
  • HALO $18.01
  • TPG $24.30
  • P/E Ratio
  • HALO $14.92
  • TPG $16,303.55
  • Revenue Growth
  • HALO 25.64
  • TPG 44.34
  • 52 Week Low
  • HALO $42.01
  • TPG $37.52
  • 52 Week High
  • HALO $70.51
  • TPG $72.98
  • Technical
  • Relative Strength Index (RSI)
  • HALO 46.43
  • TPG 45.25
  • Support Level
  • HALO $54.00
  • TPG $47.20
  • Resistance Level
  • HALO $56.39
  • TPG $48.53
  • Average True Range (ATR)
  • HALO 2.34
  • TPG 1.19
  • MACD
  • HALO 0.21
  • TPG -0.34
  • Stochastic Oscillator
  • HALO 73.59
  • TPG 14.69

About HALO Halozyme Therapeutics Inc.

Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel oncology therapies. The company seeks to create therapies focused on human enzymes that alter tumors. Halozyme focuses on developing its proprietary products in therapeutic areas with a focus on oncology, and licensing its technology to biopharmaceutical companies to collaboratively develop products. The company's operations are based in the United States, with minimal long-lived assets located internationally.

About TPG TPG Inc.

TPG Inc is an alternative asset firm. It invests across five multi-product platforms namely Capital, Growth, Impact, Real Estate, and Market Solutions. TPG aims to build dynamic products and options for its clients while also instituting discipline and operational excellence across the investment and performance of its portfolio.

Share on Social Networks: